Oncology, CNS & Neuroscience and Rare Disease are our core therapeutic areas.
Project and consulting work spans each area broadly. Our first live, structured product is in Oncology.
Solid tumours and haematological malignancies, covered broadly for project work — with one segment developed as a continuously maintained structured dataset.
Explore area →Competitive and clinical intelligence across CNS indications, with particular attention to endpoint selection, placebo response, and regulatory precedent.
Explore area →Landscape, diligence, and monitoring support across rare disease clusters — organized by gene, pathway, and modality rather than as one undifferentiated market.
Explore area →